Patel Dinesh V PH D's Form 4 filing
Protagonist Therapeutics, Inc (PTGX) · filed Mar 25, 2026
- Accession no.
- 0001104659-26-034736
- Filed
- Mar 25, 2026
- Trade date
- Mar 23-25, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $5.52M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Patel Dinesh V PH DCIK 0001120477 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 23, 2026 | Common Stock | GGiftDisposed | −50,000 | $0.00 | $0 | 524,938 | Direct | |
| Mar 24, 2026 | Common Stock | MOption exerciseAcquired | +59 | $8.58 | +$506.22 | 524,997 | Direct | |
| Mar 24, 2026 | Common Stock | SSaleDisposed | −59 | $101.00 | −$5,959 | 524,938 | Direct | |
| Mar 25, 2026 | Common Stock | MOption exerciseAcquired | +54,641 | $8.58 | +$468,819.78 | 579,579 | Direct | |
| Mar 25, 2026 | Common Stock | SSaleDisposed | −54,641 | $101.00 | −$5,518,741 | 524,938 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 24, 2026 | Common Stock | MOption exerciseDisposed | −59 | $0.00 | $0 | 54,641 | Direct | |
| Mar 25, 2026 | Common Stock | MOption exerciseDisposed | −54,641 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.